Cargando…

Successful Therapy for Myocarditis Concomitant With Complete Heart Block After Pembrolizumab Treatment for Head and Neck Squamous Cell Carcinoma: A Case Report With Literature Review

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy over the past decade. Despite their beneficial effects on treating numerous types of tumors, cardiotoxicity resulting from ICIs is a rare side effect but a concerning one due to its high mortality rate. We herein describe a case...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Lina, Liu, Chuanfen, Wu, Wenjie, Cui, Yuxia, Wu, Manyan, Chen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133913/ https://www.ncbi.nlm.nih.gov/pubmed/35647073 http://dx.doi.org/10.3389/fcvm.2022.898756

Ejemplares similares

Incidence and predictors of left ventricular function change following ST-segment elevation myocardial infarction
por: Liu, Chuanfen, et al.
Publicado: (2023)

Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block
por: Hu, Chunhong, et al.
Publicado: (2022)

Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring
por: Katsume, Yumi, et al.
Publicado: (2018)

Near complete response to a pembrolizumab-based therapeutic strategy in an abdominal metastatic head and neck squamous cell carcinoma case
por: Wu, Taowei, et al.
Publicado: (2022)

Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
por: Chen, Wen-Chun, et al.
Publicado: (2017)

Decreased miR-92a-3p expression potentially mediates the pro-angiogenic effects of oxidative stress-activated endothelial cell-derived exosomes by targeting tissue factor
por: Li, Sufang, et al.
Publicado: (2020)

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma
por: Spathas, Nikolaos, et al.
Publicado: (2018)

Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy
por: Haque, Sulsal, et al.
Publicado: (2017)

Biomarkers predictive of response to pembrolizumab in head and neck cancer
por: Pfister, David G., et al.
Publicado: (2022)

Case Report: Successful Concomitant Pulmonary Thromboendarterectomy and Carotid Endarterectomy
por: Liu, Zhan, et al.
Publicado: (2022)

Pembrolizumab in Asia‐Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE‐012
por: Tahara, Makoto, et al.
Publicado: (2018)

New developments in the management of head and neck cancer – impact of pembrolizumab
por: Saleh, Khalil, et al.
Publicado: (2018)

Vitiligoid hypopigmentation associated with pembrolizumab in metastatic head and neck cancer
por: Bulbul, Ajaz
Publicado: (2019)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
por: Jacinto, Alexandre Arthur, et al.
Publicado: (2018)

Successful rescue of fulminant myocarditis with mechanical circulatory support and immunosuppression therapy: A case report
por: Zhou, Chi
Publicado: (2023)

Successful Prevention of Fetal Autoimmune-Mediated Heart Block by Combined Therapies With Hydroxychloroquine and Intravenous Immunoglobulin: A Case Report
por: Zhao, Li, et al.
Publicado: (2021)

Cost-Effectiveness of Pembrolizumab Regimens for the First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Argentina
por: Wurcel, Victoria, et al.
Publicado: (2021)

High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Chauffert, Bruno, et al.
Publicado: (2023)

Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas
por: Wang, Kai, et al.
Publicado: (2023)

Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
por: McCusker, Michael G, et al.
Publicado: (2020)

Case Report: Fulminant Myocarditis Successfully Treated With Extracorporeal Membrane Oxygenation in Ikeda Strain Orientia tsutsugamushi Infection
por: Park, Hyejin, et al.
Publicado: (2021)

Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer
por: Harrington, K.J., et al.
Publicado: (2020)

Cost-Effectiveness Analysis Of Pembrolizumab In The Treatment Of Advanced Recurrent Metastatic Head And Neck Squamous Cell Carcinoma In China And The United States
por: Liu, Maobai, et al.
Publicado: (2019)

Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
por: Taylor, Matthew H., et al.
Publicado: (2022)

Statin-Induced Myositis with Concomitant Myocarditis
por: Patail, Haris, et al.
Publicado: (2022)

Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
por: van Baar, Mireille L.M., et al.
Publicado: (2019)

Complete heart block due to diphtheritic myocarditis in the present era
por: Varghese, Mithun J, et al.
Publicado: (2013)

Pembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy
por: Dalal, Fazal, et al.
Publicado: (2022)

Case report: Electrocardiographic changes in pembrolizumab-induced fatal myocarditis
por: Nishiyama, Kazuhiro, et al.
Publicado: (2023)

Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2023)

Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017
por: Dai, Haijiang, et al.
Publicado: (2021)

Successful Treatment of Refractory Squamous Cell Cancer of the Head and Neck with Nivolumab and Ipilimumab
por: Schwab, Katjana S., et al.
Publicado: (2018)

Clinical Identification and Characteristic Analysis of Giant Cell Myocarditis in 12 Cases
por: Liu, Shangyu, et al.
Publicado: (2021)

Survival Outcomes of Complete Pulmonary Metastasectomy for Head and Neck Squamous Cell Carcinomas
por: Kuroda, Hiroaki, et al.
Publicado: (2022)

Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis
por: Kao, Hsiang-Fong, et al.
Publicado: (2022)

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
por: Harrington, Kevin J., et al.
Publicado: (2023)

Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes
por: Hu, Yuxiao, et al.
Publicado: (2021)

Successful treatment of fulminant myocarditis with intra-aortic balloon pump counterpulsation combined with immunoglobulin and glucocorticoid in a young male adult
por: Li, Huanhuan, et al.
Publicado: (2022)

Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review
por: Wu, Lujin, et al.
Publicado: (2021)

Myocarditis in Humans and in Experimental Animal Models
por: Błyszczuk, Przemysław
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_udblkiu7q779ueu1q3dinu8bpa